Team

Management

John A. Zebala, MD, PhD

John A. Zebala, MD, PhD

President and CEO
Stuart Kahn, MD

Stuart Kahn, MD

Medical Director
Dean Y. Maeda, PhD

Dean Y. Maeda, PhD

– Director Medicinal Chemistry and Preclinical Development

Board of Directors

John A. Zebala, MD, PhD

John A. Zebala, MD, PhD

President and CEO
Mark Mendel, PhD

Mark Mendel, PhD

Board Member*
Larry Fritz, PhD

Larry Fritz, PhD

Board Member*

Scientific and Clinical Advisors and Collaborators

Martin “Mac” Cheever, MD

Martin “Mac” Cheever, MD

Fred Hutchinson Cancer Center
Ronald DePinho, MD

Ronald DePinho, MD

MD Anderson Cancer Center
Keith Flaherty, MD

Keith Flaherty, MD

Massachusetts General Hospital and Harvard Medical School
Dimitry Gabrilovitch, MD, PhD

Dimitry Gabrilovitch, MD, PhD

Wistar Institute
McGarry Houghton, MD

McGarry Houghton, MD

Fred Hutchison Cancer Center
Rami Komrokji, MD

Rami Komrokji, MD

Moffitt Cancer Center
Elizabeth Mittendorf, MD, PhD

Elizabeth Mittendorf, MD, PhD

Brigham and Women’s, Dana-Farber Cancer Institute
Jeffrey Schlom, PhD

Jeffrey Schlom, PhD

National Cancer Institute
Nat Katz, MD, MS

Nat Katz, MD, MS

Analgesic Solutions, Inc.
William Schmidt, PhD

William Schmidt, PhD

NorthStar Consulting
Robert Dworkin, MD

Robert Dworkin, MD

University of Rochester Medical Center
David Linehan, MD

David Linehan, MD

Wilmot Cancer Institute of the University of Rochester
Bitnami